People

Marc Adesso Baker Botts Austin
Marc J. Adesso
Special Counsel

Overview

Marc Adesso is Special Counsel in the Corporate Department of Baker Botts. His practice focuses on capital markets, venture capital, and cutting edge emerging companies matters. Marc's practice focuses on representing emerging and established capital markets participants, including issuers, underwriters, and C-Suite executives.

Mr. Adesso has extensive experience in the representation of public and private businesses, investment banks, funds and investors in connection with securities offerings and venture capital transactions, with particular focus on the technology industry.

He regularly advises his public company clients with corporate governance issues and securities law disclosure and compliance issues, including Exchange Act and Section 16 reporting obligations.

In addition, Mr. Adesso is internationally recognized for his experience in structuring and executing transactions in the U.S., Asia, Latin America and Europe.

Admissions & Affiliations

  • State Bar of Texas 
  • United States Tax Court

Education

  • J.D., Marquette University Law School 2010
  • M.B.A., International Management & Finance, Thunderbird School of Global Management 2008
  • M.A., Italian Literature, New York University 2004
  • B.A., Industrial Psychology & Italian, University of Wisconsin 2001

Experience

  • Acted as U.S. securities counsel for SPAC in $1.9 billion cross-border de-SPAC transaction relating to U.S. based Multi-State Operator (“MSO”)
  • Represented NYSE-listed self-storage REIT in connection with a $1.4 billion cash-out merger
  • Represented U.S.-based SPAC in $1 billion de-SPAC with alternative energy motor vehicle manufacturer
  • Assisted NYSE-listed residential REIT with securing $750 million credit facility, completing $400 million bond offering and $350 million ATM offering
  • Represented physician practice group seller in $475 million leveraged buy-out (via merger) by Chicago’s largest private equity group
  • Served as U.S. counsel for $650 million Luxembourg SICAR focused on fine art financing through one of the world’s largest art gallery conglomerates
  • Counseled NYSE-listed healthcare REIT in support of $247 million underwritten equity offering
  • Assisted an equipment leasing fund managed by Australia’s largest financial institution with fund management issues and Exchange Act reporting obligations
  • Sellers’ counsel in largest cannabis license sale in the State of Florida (transaction size of approximately $156 million)
  • Assisted Nasdaq-listed behavioral health services provider in complying with its obligations related to $143 million block trade
  • Represented acquiror in purchase of SPAC sponsor, for $150 million SPAC focused on healthcare industry
  • Represented $100 million SPAC focused on digital media industry in formation and IPO
  • Represented Singapore-based, digital maritime logistics provider in $50 million IPO and Nasdaq listing
  • Led formation of cannabis-focused REIT and $28.3 million financing involving the world’s largest cannabis MSO
  • Assisted Nasdaq-listed bank holding company with $75 million Rule 144A subordinated note offering
  • Acted as lead counsel in several ICOs for cryptocurrency issuers, including the first issuer in history to file an S-1 registration statement with the Securities and Exchange Commission
  • Represented first cannabis cultivator in history to have its Form S-1 declared effective by the Securities and Exchange Commission, as well as first MSO incorporated in Delaware to file a Form S-1 in connection with its initial public offering on the Canadian Stock Exchange
  • First cannabis industry Form 1-A to be qualified without any comments by the Securities and Exchange Commission
  • Act as lead counsel in cannabis industry joint venture with Israeli government agency
  • Act as lead counsel in MSO client’s successful bid for joint venture with major Southern university
  • Act as ’34 Act/periodic reporting and outside general counsel for public companies of varying sizes from emerging growth to WKSIs in numerous industries, including REITs, technology companies, healthcare companies, life science companies, financial institutions, fintech companies, luxury goods, and consumer/retail companies